David Donnay Rowland

EVP David Donnay Rowland sold 5,000 TRV shares at $371.69; 4 of 5 prior same-ticker sells were well-timed at 90-day mark.

David Donnay Rowland, EVP & Co-Chief Investment Officer, sold 5,000 shares of Travelers at $371.69, reducing his non-derivative holdings by 32.3% to 10,478 shares while retaining 22,755 stock options. His timing acumen on this ticker is notable: 4 of 5 prior sells at TRV were well-timed, with negative 90-day returns suggesting he consistently sold before declines. His cross-ticker track record also shows a 66.67% well-timed rate across 6 prior sales, though this current transaction occurred 0.5% below the 52-week high and at a point when the stock was up 20.7% over 30 days and 27.9% over 90 days, contrasting with his historical pattern. The company fundamentals remain solid (P/E 9.73, $12.2B revenue, $2.2B net income, 5.2% annual revenue growth), so the sale appears discretionary rather than necessity-driven.

EVP Donnay sold 4,731 shares of TRV at $308.52; stock near 52-week highs, holdings reduced 31.1%.

Rowland David Donnay sold 4,731 shares at $308.52 on 2026-02-26, reducing his holdings by 31.1% and representing $1,459,603.86 in proceeds. The transaction occurred with TRV trading near its 52-week high of $308.64, having appreciated 9.4% over the prior 30 days and 5.4% over 90 days. At the same-ticker level, Donnay's prior 5 trades at TRV show mixed 90-day outcomes: 3 of 5 sales resulted in stock declines afterward (well-timed), while 2 were followed by gains. The current sale's placement near the 52-week peak is noteworthy against a company with strong fundamentals—$12.5B quarterly revenue, $1.9B net income, and a P/E of 9.32—but without explicit rationale disclosed, the sale's motivations remain opaque.

EVP Donnay sells 5,000 TRV shares at $290.57; 3 of 4 prior TRV sales were well-timed at 90-day mark.

Rowland David Donnay sold 5,000 shares of Travelers at $290.57, reducing his stake by 22.2% to 17,562 shares post-transaction. This represents a modest divestiture in absolute terms ($1,452,849.00), though the percentage reduction is material relative to his prior holdings. Donnay's track record at TRV specifically shows 3 of 4 prior sells were well-timed at the 90-day mark, with an average 90-day return of -3.3% across those four sales, suggesting pattern recognition in exits. The current price of $290.84 sits at the 52-week high, having risen 7.8% in the past 30 days and 7.4% over 90 days, which contextualizes this sale near recent strength rather than capitulation. The company's fundamentals remain solid with P/E of 11.05 and recent annual revenue growth of 12.2%, though the timing pattern warrants observation.

EVP Rowland David Donnay sold 12,069 shares of TRV at $274.01 for $3,307,003.76, reducing holdings by 50.7%.

Donnay sold 12,069 shares (50.7% of his pre-transaction holdings), a material reduction in position size. His cross-ticker track record shows 3 prior sells with an average 90-day return of -3.0% and a 90d well-timed rate of 66.67%, but his same-ticker history at TRV is mixed: 2 of 3 prior TRV sales were well-timed at the 90-day mark, though the most recent TRV sale on 2024-11-26 showed -7.5% at 30 days. The stock is currently near its 52-week high at $275.70 (within 0.1% of the $275.88 peak) and has risen 4.4% over the past 30 days and 6.7% over 90 days. The company shows solid fundamentals with $11.8B in revenue, +12.2% annual growth, and a 14.63 P/E ratio, providing no obvious distress signal. The timing and magnitude of this sale merit monitoring to assess whether it signals a directional view or reflects other considerations.

EVP Donnay sold 4,000 TRV shares at $263.44; stock near 52-week high, prior two TRV sales poorly timed.

Rowland David Donnay, EVP & Co-Chief Investment Officer, sold 4,000 shares (38.1% of pre-transaction holdings) on 2024-11-26 at $263.44, reducing his position from 10,505 to 6,505 shares for $1,053,776.00 total value. The sale occurred at the current 52-week high ($266.66 current price, +0.0% from 52-week high), yet his prior two sales at TRV on 2024-02-27 and 2024-02-02 were poorly timed—both followed by positive 90-day returns (+−3.4% and +0.2%), meaning he sold before rallies. While TRV itself shows solid fundamentals (Revenue $11,904,000,000.00, Net income $1,260,000,000.00, P/E of 13.33), the timing pattern across his same-ticker history (1 of 2 prior sells well-timed at the 90-day mark) offers limited predictive signal for this transaction's quality.